• Company
  • About Us
About Us

HUINNO, Promoting Digital Healthcare with Progressive Diagnosis Solutions

HUINNO is a digital healthcare company committed to research and development of services and solutions for the early diagnosis of cardiovascular disease, the leading cause of death across the globe.

Our original wearable devices are designed to monitor crucial biosignals and employ AI-based algorithms to provide a rapid and precise analysis, helping providers make more informed decisions and diagnoses.

Vision & Mission

Innovating Healthcare
We pioneer AI-based digital healthcare technology with the goal of preventing diseases and enhancing the quality of life.

History

We continue to produce meaningful solutions for both patients and medical professionals.

  • 2025

    MAY

    Memo Band obtained MFDS medical device item approval.

    MAR

    Obtained insurance reimbursement code for remote heart monitoring technology (EX871)

  • 2024

    DEC

    Selected as an Excellent Work-Life Balance Company in Korea

    Selected as a Family-Friendly Certified Company

    NOV

    Received the Minister of Science and ICT Award at the Korea Invention Patent Exhibition

    MAY

    Acquired certifications for ISO 27001 / ISO 27701 / HIPAA (Information Security Management Systems)

  • 2023

    FEB

    Receives an award from the Minister of Health and
    Welfare for Korea Medical Devices Industry Association
    at the regular general meeting merit awards

    Enters into an ECG analysis MOU with Bucheon Sejong Hospital

  • 2022

    DEC

    Establishes KHAIM, a joint venture with Korea University Holdings

    Receives award from the Minister of Health and Welfare for
    contributing to the health and medical service technology business

    Selected to present at the J.P. Morgan Healthcare Conference,
    Global IR @JPM

    AUG

    Receives seed funding for HUINNO AIM (4 billion KRW)

    Selected as a usability assessment company with
    the Ministry of Food and Drug Safety’s recently adopted
    international standards for the latest medical devices

    Enters into a data-driven arrhythmia diagnosis and
    treatment MOU with Johnson & Johnson Medical Korea

    JUN

    Selected as a representative company for
    the biohealth sector regulation and innovation meeting by
    Ministry of Health and Welfare

    MAR

    Enters into a domestic copyright agreement for
    MEMO Patch with Yuhan Corporation

    Receives Best Companies Award at
    the Health 2.0 Conference in Dubai

    FEB

    Founds subsidiary HUINNO AIM

  • 2021

    DEC

    Selected as an outstanding 2021 R&D business by
    Seoul Business Agency

    Secures Series C Funding (43.5 billion KRW)

    SEP

    Ranks 2nd among all-lead ECG devices and
    1st place for 6 & 4 lead ECG at
    the Global AI Challenge, PhysioNet

    JUN

    Selected as a Top 20 MedTech Innovator Asia-Pacific company

    APR

    Acquires a production license for
    the MEMO Patch medical device

    MAR

    Enters into an arrhythmia diagnosis and
    treatment MOU with Johnson & Johnson Medical Korea

    Headquarters relocates
    (from Seoul Biohub in Hoegi-dong, Dongdaemun-gu District,
    to Cheongdam-dong, Gangnam-gu District)

    MEMO Patch receives reimbursement from
    the Health Insurance Review and Assessment Service
    as a wearable ECG device

    Enters into a listed lead manager agreement with
    NH Investment & Securities

    FEB

    Receives MEMO Watch CE certification

  • 2020

    DEC

    MEMO Patch receives the first u-Healthcare ECG certification
    in Korea from the Ministry of Food and Drug Safety

    Secures Series B funding (20 billion KRW)

    Receives an award from the Minister of Science and ICT
    at the ICT Innovation Awards

    MAY

    MEMO Watch becomes the first wearable ECG device in
    Korea to receive reimbursement from
    the Health Insurance Review and Assessment Service

    MAR

    Clinical trials start for remote monitoring with MEMO Watch,
    the first wearable ECG device in Korea

    Ranks 2nd in the creativity and innovation category
    at the LINA Foundation’s 50+ Awards

    FEB

    Receives strategic funding from Yuhan Corporation
    (5 billion KRW)

  • 2019

    JUL

    Secures Series A funding (8.4 billion KRW)

    MAR

    First wearable ECG device in Korea to receive
    certification from the Ministry of Food and Drug Safety

    FEB

    Selected as the first company in the ICT fusion category
    for the regulatory sandbox in Korea

  • 2018

    DEC

    Selected as a partner company of
    the Korea Institute of Industrial Technology

    SEP

    Selected for Next Generation Medical Device 100
    Project Mentoring by the Ministry of Food and Drug Safety

    MAY

    Receives an award from the Minister of Science and
    ICT at the pitching contest for ICT venture funding

  • 2017

    DEC

    Awarded grand prize at the Seoul Innovation Challenge
    held by the Seoul Business Agency

  • 2015

    DEC

    Selected as a member of the K-Global 300
    by the Ministry of Science, ICT and Future Planning

    NOV

    Ranks 1st place at K Global @ Silicon Valley 2015

    JUL

    Selected as the Korean representative for
    the ERA Program in New York, USA (KOTRA)

    JUN

    Selected for the promising ICT development
    and support program by the Ministry of Science,
    ICT and Future Planning

    Selected as a patent star company by
    the Seongnam Municipal Government in
    Gyeonggi-do Province

  • 2014

    JUL

    HUINNO is founded

Leadership

  • Yeongjoon Gil, Ph.D.

    CEO / Founder

    Pusan National Univ. Ph.D. in Computer Science & Engineering

    • Pusan National Univ. Adjunct Professor Computer Science & Engineering
    • Pusan National Univ. Postdoctoral Research Fellow
  • Sophie Lee

    COO / Deputy CEO

    Seoul National Univ. B.A. in French

    • COO, JEJU Beer Company Co.,Ltd.
    • Exec. Director & Founding Member, FOREST PARTNERS, LLC
    • COO & CFO, SUNTEL Co.,Ltd.(prev. VISIONSCAPE)
    • VP, Operation Team, BRV KOREA ADVISORS Co.,Ltd.
    • CSO, YOUNG TOYS, Inc.
  • Sunghoon Jung, Ph.D.

    CTO / Deputy CEO

    Pusan National Univ. Ph.D. in Computer Science & Engineering

    • Pusan National Univ. Postdoctoral Research Fellow
    • CSO, Leafmill Co.,Ltd.
  • Caleb Choo, Ph.D.

    CRIO / Technical Director

    Pusan National Univ. Ph.D. in Computer Science & Engineering

    • CSO / Executive Vice President, Bodit Inc.
    • Senior Director, Corporate Growth Division, Seoul Business Agency (SBA)
    • CSO / CTO, FIT Inc.
    • CEO / CTO & Founder, HUMBLE
    • Head of R&D / Marketing Division & Founding Member, WIZnet Inc.

Main Investors

Total investment amounts to 80 billion KRW. Series C funding has now been secured.

Main investors

  • Smilegate

  • Yuhan

  • Woori Venture Partners

  • Future Play

Main partners

  • Yuhan

  • J&J